Alga Biologics, a prodigy in maritime biomanufacturing
A laureate of Gene.iO’s third yearly program and a specialist in the use of microalgae for the bioproduction of therapeutic antibodies,
Alga Biologics, was among the 35 start-ups included in the French Blue Tech Index on 18 December. Furthermore, the company won the Indosuez Special Prize, presented by Jacques Prost, CEO of Indosuez Wealth Management Group, in recognition of the societal and environmental impact of its project.
The French Blue Tech Index is edited by Cluster Maritime Français, a professional organization uniting maritime corporations, and under the aegis of the French State Secretariat for the Sea with the Indosuez Wealth Management Group.
The index’s objective is to increase visibility for the sector’s most-promising start-ups and to facilitate opportunities with investors.
Headed by Muriel Bardor and Catherine Gallot, Alga Biologics has developed an antibody bioproduction process that brings several advantages to the table compared to current, conventional production methods, including lower manufacturing costs, improved antibody quality and reduced environmental impacts.
Fungu’it and Alt Biotech: promising innovations
Two other Gene.iO third-year laureates, Fungu’it and Alt Biotech, were selected to participate in 212 Founders, a start-up accompaniment and financing program by CDG Invest, Morocco’s primary institutional investor.
That program comprises an initial incubation phase followed by an acceleration phase and targets the emergence of global-scale startups in connection with Morocco and France. 212 Founders can function concurrently with Gene.iO.
Fungu’it, cofounded by Anas Erridaoui and Jeanne Baudevin, produces proteinaceous ingredients via fungal solid-state fermentation while valorizing agricultural by-products with its process. The company’s ingredients are intended for the food & agriculture industry, where they provide more naturalness and reduce ultra-processing.
Alt Biotech, cofounded by Sakina Elkassouani and Jade Pellet, has developed an innovative biomanufacturing method for recombinant proteins that speed cell culturing.
The company was also a finalist in Hello Tomorrow’s Global Challenge in the Industrial Biotech & New Materials category.
